Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Keegan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|May 15, 1982
Inactivation of angiotensin II receptors in bovine adrenal cortex by dithiothreitol: further evidence for the essential nature of disulfide bondsR S Chang, V J Lotti, M E Keegan
The American Journal of Cardiology|February 21, 1989
Tolerability of enalapril in congestive heart failureN J Warner, J E Rush, M E Keegan
Neuroscience Letters|December 12, 1986
Tifluadom, a kappa-opiate agonist, acts as a peripheral cholecystokinin receptor antagonistR S Chang, V J Lotti, T B Chen, et al.
Biochemical and Biophysical Research Communications|January 29, 1986
Characterization of [3H]pentagastrin binding in guinea pig gastric glands--an alternative convenient ligand for receptor binding assayR S Chang, V J Lotti, M E Keegan, et al.
Federation Proceedings|August 1, 1986
Molecular characteristics of receptors for atrial natriuretic factorR L Vandlen, K E Arcuri, L Hupe, et al.
Journal of Hypertension|August 1, 1988
Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic ratsJ F Hartmann, M Szemplinski, N S Hayes, et al.
The American Journal of Cardiology|November 1, 1991
Long-term safety and efficacy profile of simvastatinS J Boccuzzi, T S Bocanegra, J F Walker, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscleR J Winquist, M A Napier, R L Vandlen, et al.
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|May 15, 1982
Inactivation of angiotensin II receptors in bovine adrenal cortex by dithiothreitol: further evidence for the essential nature of disulfide bondsR S Chang, V J Lotti, M E Keegan
The American Journal of Cardiology|February 21, 1989
Tolerability of enalapril in congestive heart failureN J Warner, J E Rush, M E Keegan
Neuroscience Letters|December 12, 1986
Tifluadom, a kappa-opiate agonist, acts as a peripheral cholecystokinin receptor antagonistR S Chang, V J Lotti, T B Chen, et al.
Biochemical and Biophysical Research Communications|January 29, 1986
Characterization of [3H]pentagastrin binding in guinea pig gastric glands--an alternative convenient ligand for receptor binding assayR S Chang, V J Lotti, M E Keegan, et al.
Federation Proceedings|August 1, 1986
Molecular characteristics of receptors for atrial natriuretic factorR L Vandlen, K E Arcuri, L Hupe, et al.
Journal of Hypertension|August 1, 1988
Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic ratsJ F Hartmann, M Szemplinski, N S Hayes, et al.
The American Journal of Cardiology|November 1, 1991
Long-term safety and efficacy profile of simvastatinS J Boccuzzi, T S Bocanegra, J F Walker, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscleR J Winquist, M A Napier, R L Vandlen, et al.
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Pageof 1